Clonality: kit
Source: Accurate
Cat #





Comments / Questions

No Available Comments

Make a comment or submit a question

To make a comment you must login or register.


No Available References

Further Reading


  1. Network Diagnostics: "Default-Mode" Brain Areas Identify Early AD
  2. Anti-Amyloid Treatment in Asymptomatic AD Trial
  3. NIH Director Announces $100M Prevention Trial of Genentech Antibody
  4. A Close Look at Passive Immunotherapy Newbie, Crenezumab
  5. Colombians Come to Fore in Alzheimer’s Research, Mass Media
  6. Miami: When Does Amyloid Deposition Start in Familial Alzheimer’s?
  7. Experimental α7 Agonist Meets Cognitive and Clinical Endpoints
  8. Q&A With Roche’s CNS Leader Luca Santarelli
  9. When Is a C9ORF72 Repeat Expansion Not a C9ORF72 Repeat Expansion?
  10. Wave of New BACE Inhibitors Heading to Phase 2
  11. Researchers Join to Draw Posterior Cortical Atrophy Out of Shadows
  12. CSF Markers: Goodbye, Research Use Only; Hello, Clinical
  13. Cochrane Asks for Field’s Input on Draft Reporting Standards
  14. Collaborative Umbrella CAPs Three Prevention Trial Initiatives
  15. DIAN: Registry for eFAD to Chart Alzheimer’s Preclinical Decade
  16. Reeling In Biomarker Data in Young Carriers, API Rocks Staging Boat
  17. DIAN Dispatch from Hawaii: Glimpse at Data, Push for Trials
  18. DIAN Forms Pharma Consortium, Submits Treatment Trial Grant
  19. DIAN Grows, Gets Ready for Therapeutic Trials
  20. New Assays for Aβ Oligomers in CSF Claim Femtogram Sensitivity
  21. Metrology, Certification Heavies Take CSF Tests Under Their Wings
  22. Can We All Agree on How to Draw a Hippo(campus)?
  23. On Risk, Benefit, and More, Prevention Initiatives Take Questions